Resources from the same session
Discussion - Unmet needs in the management of EGFR+ NSCLC
Presenter: Benjamin Besse
Session: Janssen Pharmaceutica - Evolving treatment options and practices in EGFR-mutant NSCLC
Resources:
Webcast
Discussion - Advances in the treatment of patients with EGFR exon20ins+ NSCLC
Presenter: Anna Minchom
Session: Janssen Pharmaceutica - Evolving treatment options and practices in EGFR-mutant NSCLC
Resources:
Webcast
Live Q&A
Presenter: Enriqueta Felip
Session: Janssen Pharmaceutica - Evolving treatment options and practices in EGFR-mutant NSCLC
Resources:
Webcast